Hoping for Cures, Supporters May Back Another Ballot Measure for Stem Cell Agency
<p>
Touted seven years ago as a way to develop "breakthrough cures" for an array of life-threatening ailments, California's $3 billion taxpayer-financed stem cell agency still has no treatments on the market and is at a critical juncture that could determine how much longer it stays in operation.<br />
<br />
